Abbott Laboratories ABT
103.87 USD -0.61 (-0.58%)
Regular-session close
103.55 -0.32 -0.31%
After hours · Nov 19, 4:57 PM ET
103.61 Day range 105.83
81.97 52-week range 129.85
- YTD
- -17.10%
- 1 year
- -17.66%
ABT revenue history
Revenue is income from the company’s ordinary business activities.
44,328,000,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 44,328,000,000 | 2,378,000,000 | 5.67% |
| FY 2024 | 2024-12-31 | 41,950,000,000 | 1,841,000,000 | 4.59% |
| FY 2023 | 2023-12-31 | 40,109,000,000 | -3,544,000,000 | -8.12% |
| FY 2022 | 2022-12-31 | 43,653,000,000 | 578,000,000 | 1.34% |
| FY 2021 | 2021-12-31 | 43,075,000,000 | 8,467,000,000 | 24.47% |
| FY 2020 | 2020-12-31 | 34,608,000,000 | 2,704,000,000 | 8.48% |
| FY 2019 | 2019-12-31 | 31,904,000,000 | 1,326,000,000 | 4.34% |
| FY 2018 | 2018-12-31 | 30,578,000,000 | 3,188,000,000 | 11.64% |
| FY 2017 | 2017-12-31 | 27,390,000,000 | 6,537,000,000 | 31.35% |
| FY 2016 | 2016-12-31 | 20,853,000,000 | 448,000,000 | 2.20% |
| FY 2015 | 2015-12-31 | 20,405,000,000 | 158,000,000 | 0.78% |
| FY 2014 | 2014-12-31 | 20,247,000,000 | 590,000,000 | 3.00% |
| FY 2013 | 2013-12-31 | 19,657,000,000 | 607,000,000 | 3.19% |
| FY 2012 | 2012-12-31 | 19,050,000,000 | -2,357,000,000 | -11.01% |
| FY 2011 | 2011-12-31 | 21,407,000,000 | -13,759,721,000 | -39.13% |
| FY 2010 | 2010-12-31 | 35,166,721,000 | 4,402,014,000 | 14.31% |
| FY 2009 | 2009-12-31 | 30,764,707,000 | 1,237,155,000 | 4.19% |
| FY 2008 | 2008-12-31 | 29,527,552,000 | 3,613,314,000 | 13.94% |
| FY 2007 | 2007-12-31 | 25,914,238,000 | 3,437,916,000 | 15.30% |
| FY 2006 | 2006-12-31 | 22,476,322,000 | 138,514,000 | 0.62% |
| FY 2005 | 2005-12-31 | 22,337,808,000 | 2,657,792,000 | 13.51% |
| FY 2004 | 2004-12-31 | 19,680,016,000 | 2,399,683,000 | 13.89% |
| FY 2003 | 2003-12-31 | 17,280,333,000 | 2,000,796,000 | 13.09% |
| FY 2002 | 2002-12-31 | 15,279,537,000 | -1,005,709,000 | -6.18% |
| FY 2001 | 2001-12-31 | 16,285,246,000 | 2,539,330,000 | 18.47% |
| FY 2000 | 2000-12-31 | 13,745,916,000 | 568,291,000 | 4.31% |
| FY 1999 | 1999-12-31 | 13,177,625,000 | 664,891,000 | 5.31% |
| FY 1998 | 1998-12-31 | 12,512,734,000 | 623,451,000 | 5.24% |
| FY 1997 | 1997-12-31 | 11,889,283,000 | 875,823,000 | 7.95% |
| FY 1996 | 1996-12-31 | 11,013,460,000 | 1,001,266,000 | 10.00% |
| FY 1995 | 1995-12-31 | 10,012,194,000 | 856,185,000 | 9.35% |
| FY 1994 | 1994-12-31 | 9,156,009,000 | 748,166,000 | 8.90% |
| FY 1993 | 1993-12-31 | 8,407,843,000 | 555,931,000 | 7.08% |
| FY 1992 | 1992-12-31 | 7,851,912,000 | 975,324,000 | 14.18% |
| FY 1991 | 1991-12-31 | 6,876,588,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-25T06:02:03.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
